Here are five gastroenterologists in the news this past week.
GI & Endoscopy
Jonathan A. Dranoff, MD, is a gastroenterologist at the Fayetteville-based University of Arkansas for Medical Center.
Marlborough, Mass.-based Boston Scientific officially acquired the LumenR Tissue Retractor System from Newark, Calif.-based LumenR.
The American Journal of Gastroenterology is telling physicians what not to do in their practices with their most recent edition, The Negative Issue.
Data related to obeticholic acid will be presented at the American Association for the Study of Liver Diseases' annual meeting, according to New York-based biopharmaceutical company Intercept Pharmaceuticals.
Paul Anderson, MD, is a gastroenterologist at the Oregon City-based Oregon Clinic.
In 2012, there were 3.5 million cancer deaths among women across the globe — this number is projected to increase to 5.5 million cancer deaths by 2030, according to an American Cancer Society report on the global burden of cancer…
Of the 15 million colonoscopies performed worldwide, nearly 20 percent are poorly prepped; however Motus GI's Pure-Vu system is "significantly" improving the patient preparation rate, Mass Device reports.
Parsippany-Troy Hills, N.J.-based Allergan completed its acquisition of San Francisco-based Tobira Therapeutics on Nov. 2, 2016, Pharmbiz.com reports.
Here are four updates on gastroenterology and endoscopy companies.
